| |
| |
|
| Insider
Information: |
Roach James M. |
| Relationship: |
Senior VP, Development... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
155,381 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,154,395 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
155,381 |
|
|
| Total
Value |
$8,154,395 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
Senior VP, Development... |
2016-11-22 |
155,381 |
2009-02-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
97 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-02-18 |
4 |
AS |
$11.91 |
$3,001 |
D/D |
(252) |
122,459 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2016-08-22 |
4 |
AS |
$12.10 |
$3,013 |
D/D |
(249) |
156,472 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2014-05-20 |
4 |
AS |
$12.08 |
$3,020 |
D/D |
(250) |
104,070 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2011-08-19 |
4 |
AS |
$15.67 |
$3,040 |
D/D |
(194) |
70,387 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2011-08-26 |
4 |
AS |
$16.07 |
$3,102 |
D/D |
(193) |
70,194 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2010-08-26 |
4 |
AS |
$16.57 |
$3,181 |
D/D |
(192) |
17,840 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-02-20 |
4 |
AS |
$13.40 |
$3,337 |
D/D |
(249) |
120,546 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2014-02-25 |
4 |
AS |
$17.47 |
$3,354 |
D/D |
(192) |
105,022 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2013-08-15 |
4 |
AS |
$15.43 |
$3,364 |
D/D |
(218) |
87,340 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2013-11-19 |
4 |
AS |
$17.17 |
$3,382 |
D/D |
(197) |
86,537 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2013-11-25 |
4 |
AS |
$17.77 |
$3,412 |
D/D |
(192) |
86,345 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2014-02-19 |
4 |
AS |
$17.86 |
$3,518 |
D/D |
(197) |
106,209 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2011-05-20 |
4 |
AS |
$18.55 |
$3,599 |
D/D |
(194) |
70,772 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2016-11-22 |
4 |
AS |
$14.40 |
$3,600 |
D/D |
(250) |
155,381 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2013-11-15 |
4 |
AS |
$16.88 |
$3,663 |
D/D |
(217) |
86,734 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2011-05-26 |
4 |
AS |
$19.20 |
$3,667 |
D/D |
(191) |
70,581 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2014-02-18 |
4 |
AS |
$17.96 |
$3,897 |
D/D |
(217) |
86,128 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2014-04-15 |
4 |
AS |
$10.76 |
$5,219 |
D/D |
(485) |
104,537 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-11-17 |
4 |
AS |
$17.65 |
$5,507 |
D/D |
(312) |
91,404 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-05-15 |
4 |
AS |
$19.96 |
$6,208 |
D/D |
(311) |
106,879 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-11-20 |
4 |
AS |
$17.75 |
$6,390 |
D/D |
(360) |
90,441 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-08-17 |
4 |
AS |
$21.67 |
$6,761 |
D/D |
(312) |
105,590 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-05-20 |
4 |
AS |
$19.68 |
$7,085 |
D/D |
(360) |
105,902 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-08-20 |
4 |
AS |
$22.20 |
$8,059 |
D/D |
(363) |
91,716 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2016-05-19 |
4 |
AS |
$10.20 |
$8,588 |
D/D |
(842) |
157,813 |
0 |
- |
|
97 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
